Background: Temporal analyses of death rates in the US have found a decreasing trend in all-cause and major cause-specific mortality rates.
INTRODUCTION
All-cause mortality rates have decreased steadily in the US in the past 3 decades, but the trends of this decrease differed by age, sex, and race/ethnicity. 1, 2 More recent trends in mortality caused by cardiovascular disease (CVD), heart disease, and stroke in the US between 2000 and 2014 indicate that the decline in death rates has slowed since 2011. 3 However, there are large geographic variations in all-cause mortality and disease-specific mortality. 4 Because mortality is an important indicator of population health, the overall and cause-specific mortality trends can inform health policy, 5 allow the identification of modifiable factors, [6] [7] [8] and guide the design of population-based and clinical care interventions.
Integrated health care delivery systems are associated with overall better adherence to evidence-based care guidelines, better survival rates, and reduced racial disparities. [9] [10] [11] Advantages of integrated health systems are their ability to coordinate care and conduct large-scale and sustained care-improvement initiatives to emphasize prevention, improve disease outcomes, and reduce mortality. 12, 13 One example is the sepsis mortality reduction initiative in 21 hospitals of Kaiser Permanente Northern California (KPNC). 14 The sepsis mortality rate at these KPNC hospitals declined from 24.6% to 11.5% in less than 3 years. 14 The reported steeper reduction of heart disease, stroke, and all-cause mortality rates among KPNC enrollees compared with those of the US population 15 could be related to the implementation of a large-scale hypertension prevention program. 16 Lower age-adjusted mortality rates have been observed in Hispanic [17] [18] [19] and Asian/ Pacific Islander populations 19 compared with that of non-Hispanic whites. Mortality rates were even lower for Hispanics than non-Hispanics after adjusting for annual family income. 17 However, not all studies support these conclusions because of the differences in the populations being studied. 17 For example, differences in mortality between Hispanics who immigrated to another country vs those who did not were noted. [20] [21] [22] [23] [24] In Southern California, the growth of Hispanic and Asian populations in the past 2 decades has been substantial. Thus, the advantage in mortality of the 2 populations could favorably affect the overall mortality rates of Kaiser Permanente Southern California (KPSC) enrollees if the mortality advantage does prevail among Hispanic and Asian/Pacific Islander populations.
Although absolute values of mortality rates are important, temporal trends in mortality are extremely informative because they could reflect changes of individual, organizational, or societal factors, including individual behaviors, medical practice (eg, change of practice guidelines or introduction of new treatments), medical technology, and the environment where people live. For example, cancer screenings can influence cancer mortality rates, and more advanced drug treatment can have an impact on the mortality rates owing to heart disease. In this study, both mortality rates and trends between 2001 and 2016 were studied for KPSC Health Plan enrollees. However, given the ethnic diversity of the KPSC and California populations compared with that of the US, we focused on mortality trends rather than the absolute values of mortality rates when the 3 populations (KPSC, CA, and the US) were compared. More specifically, the goals of this study were to 1) examine the age-adjusted mortality rates and trends of KPSC Health Plan enrollees; 2) study the age-adjusted sex-and race/ethnicityspecific mortality rates and the trends of
Study Subjects and At-risk Person-Time
Health Plan enrollees up to 110 years of age who had more than 1 day of enrollment between 2001 and 2016 were included. Enrollees whose age was missing were excluded. Those who were older than age 110 years were also removed from the analysis because they represented a very small number of enrollees, and some may have had an incorrect date of birth. Enrollees whose sex was labeled "other" or "unknown" were also excluded.
For each enrollee, the total number of days enrolled was considered the at-risk time for each calendar year. The at-risk time started from the date when the enrollee joined KPSC or January 1, whichever occurred later. The at-risk time ended at the disenrollment from the Health Plan, date of death, or December 31, whichever occurred first. Gaps in enrollment of 45 days or shorter were bridged (ie, continuous enrollment was assumed) even if the gaps spanned 2 consecutive years. For example, an enrollee who joined KPSC on July 1, 2010; terminated enrollment on November 30, 2010; rejoined on January 1, 2011; and died on October 30, 2011, contributed 6 (instead of 5) and 10 months of at-risk time in 2010 and 2011, respectively. If an enrollee had multiple enrollment periods within a calendar year that were greater than 45 days apart, the lengths of these enrollment periods were summed and the total length was designated as the at-risk time contributed by the enrollee for that specific year.
For age-specific analyses, an enrollee could contribute to at-risk periods that belonged to different age groups. For example, an enrollee who turned 65 years of age on July 1 could contribute 6 months of at-risk time to the group aged 55 to 64 years and another 6 months to the group aged 65 to 74 years. Finally, the individual-level age-, sex-, and year-specific at-risk times for each calendar year were combined to form the total at-risk person-time for that specific year. The same process was repeated for each calendar year between 2001 and 2016.
Mortality
The KPSC death records (in the Research Data Warehouse) were derived by identifying deaths that occurred at KPSC-owned facilities, outside facilities that submitted claims to KPSC, or deaths reported to the Health Plan. These records were supplemented by linking the enrollees with the decedents in the 
Statistical Analysis
The overall, sex-stratified, and race/ ethnicity-stratified age-adjusted mortality rates were calculated using the direct method 27 and the projected year 2000 US population as the standard population (Appendix 3 a ). Enrollees with race/ ethnicity other than non-Hispanic white, Hispanic, African American, and Asian/ Pacific Islander (ie, Native American, Alaskan, other, or multiple) and those with unknown race/ethnicity were included in the analyses that were not specific to race/ ethnicity.
For KPSC enrollees, we ranked the ageadjusted, cause-specific mortality rates for each calendar year. For California and the US populations, we obtained the rates only for those causes that were ranked at the top 10 in 2016 for KPSC enrollees. Deaths with unknown causes were removed from the cause-specific analyses. For each cause, we reported age-adjusted rates standardized to the projected year 2000 US population overall as well as stratified by race/ ethnicity. The analyses of CVD mortality rates (defined as the sum of heart disease and cerebrovascular disease mortality rates) were limited to adults aged 45 years or older. For comparison, we included relevant age-adjusted mortality rates for the entire US and the State of California populations. The US and California mortality rates between 2001 and 2016 were derived from the CDC's Wide-Ranging Online Data for Epidemiologic Research CDC WONDER dataset (https://wonder.cdc. gov/ucd-icd10.html). To estimate an average annual percentage change (AAPC) in mortality rates, we first calculated the annual percentage change in age-adjusted mortality rates of 2 consecutive years (ie, slope) on a log scale and then derived the geometric mean of the annual percentage changes and their 95% confidence intervals (CIs). 28 For comparison of AAPCs from 2 populations, a Z-statistic was formed by dividing the difference in the 2 AAPCs and the standard error (SE) of the difference (ie, sqrt [SE 1 2 + SE 2 2 ], where sqrt is the square root and SE 1 and SE 2 are the standard errors of the 2 individual estimates). The analysis was performed on a log scale. A test was considered statistically significant if the p value was < 0.05.
Because all-cause and cause-specific mortality rates vary considerably by age and some specific causes of mortality are more relevant for adults, we conducted sensitivity analyses for overall and sexspecific all-cause mortality, and for overall cause-specific mortality for the top 10 causes by including only adult Health Plan enrollees who were 25 or more years of age.
RESULTS
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ORIGINAL RESEARCH & CONTRIBUTIONS
Temporal Trends in Mortality Rates among Kaiser Permanente Southern California Health Plan Enrollees, 2001-2016
All-Cause Mortality

Age-Adjusted All-Cause Mortality
From 2001 to 2016, the age-adjusted, all-cause mortality rate per 100,000 person-years in KPSC decreased from 684 to 521 (AAPC -1.84, 95% CI -2.95 to -0.71; Table 2 ). During the same period, the corresponding rates in the US and California decreased from 859 to 729 (AAPC = -1.10, 95%, CI = -1.78 to -0.42) and from 783 to 617 (AAPC = -1.60, 95% CI = -2.51 to -0.69), respectively. The differences in trends between KPSC and California and between KPSC and the US were not statistically significant at the 95% level.
In KPSC, the AAPCs for males and females were -1.94 (95% CI = -2.94 to -0.93) and -1.78 (95% CI = -3.35 to -0.18), respectively, between 2001 and 2016 ( Table 2 ). The trend estimates did not differ statistically from those of California and the US. In all 3 populations, mortality rates for males appeared consistently higher than those of females (Table 2) . When the analyses were limited to adults aged 25 years or older, all the comparisons of AAPCs mentioned in this section yielded the same conclusions (data not shown).
Race/Ethnicity-Specific All-Cause Mortality
In KPSC, Asian/Pacific Islanders had the lowest age-adjusted mortality rates during the study period (377/100,000 person-years in 2016), followed by Hispanics (445/100,000), non-Hispanic whites (568/100,000) and African Americans (652/100,000; Figure 1 , Supplemental Table E1 a ). For all racial/ethnic groups (non-Hispanic whites, Hispanics, African Americans, and Asian/Pacific Islanders), the overall and sex-specific all-cause mortality rates in KPSC seemed to be consistently lower compared with those of California and the US ( Table E1 a ) . No statistically significant difference was found in the trends of race/ethnicity-specific, or race/ ethnicity-and sex-specific age-adjusted all-cause mortality rates between KPSC and California and between KPSC and the US (Supplemental Table E1 a ).
Leading Causes of Mortality
Top 10 Leading Causes of Death
Supplemental Table E2 a displays the top 10 causes of death in 2016 for KPSC and the corresponding mortality rates in California and the US. Cancer and heart disease were the leading causes of death between 2001 and 2016 for all 3 populations [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] (KPSC, California, and the US; Supplemental Table E2 a , Figure 2 ). During the last 10 years of the study period (2007 to 2016), the rank of the top 5 causes of death in KPSC remained the same (Supplemental Table E2 a ) .
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At KPSC, cancer was the leading cause of death in 2016 with 133 deaths per 100,000 person-years. The second, third, and fourth leading causes of death were heart disease (113/100,000 personyears), Alzheimer disease (39/100,000 person-years), and cerebrovascular diseases (31/100,000 person-years), respectively. During the study period, age-adjusted mortality rates of cancer (AAPC = -1.87, 95% CI = -2.75 to -0.98), heart disease (AAPC = -3.18, 95% CI = -4.78 to -1.54), and influenza and pneumonia (AAPC = -7.08, 95% CI = -13.63 to -0.04) decreased significantly (Supplemental Table E2 a ). The decrease of mortality rate for cerebrovascular diseases from 57 to 31 per 100,000 person-years was impressive; however, it was not statistically significant (AAPC = -4.42, 95% CI = -8.67 to 0.02). Decreasing trends were observed for cancer, heart disease, and cerebrovascular disease in the US and California populations. A statistically significant increase in the Alzheimer disease mortality was observed in the US (AAPC = 2.91, 95% CI = 0.14 to 5.75) and California (AAPC = 4.80, 95% CI = 1.48 to 8.23) populations, but not in the KPSC population (AAPC = 1.82, 95% CI = -2.66 to 6.50). In 2016, Alzheimer disease was ranked as the sixth leading cause of death in the US and the third leading cause of death in California. No statistically significant difference was found in the trends of any age-adjusted cause-specific mortality rates between KPSC and California, or between KPSC and the US between 2001 and 2016 for the top 10 causes of death (Supplemental Table E2 a ). When the analyses were limited to adults 25 or more years of age, the comparisons of AAPC between KPSC and the US/California yielded the same conclusions (data not shown).
Top 10 Leading Causes of Mortality by Race/Ethnicity
In KPSC, African American enrollees had the highest age-adjusted cancer and heart disease mortality rates (152 and 146/100,000 person-years in 2016, respectively), followed by non-Hispanic whites (147 and 127/100,000 personyears in 2016, respectively) (Supplemental Table E3 a ). African American and nonHispanic whites enrollees had higher mortality rates caused by Alzheimer disease, compared with Hispanics and Asian/ Pacific Islanders in all of the years studied. African American enrollees also had the highest mortality rates for diabetes mellitus during the study period, followed by Hispanics. The mortality rates of chronic lower respiratory disease and accidents were highest among non-Hispanic white enrollees. Figure 3 shows the age-adjusted mortality rates by race/ethnicity for each of the top 6 causes. The reduction in the rates of cancer mortality between 2001 and 2016 seemed to be larger in Asian/Pacific Islander (AAPC = -3.20; 95% CI = -8.81 to 2.76) and African Americans (AAPC -2.74, 95% CI -5.48 to 0.09), compared with those of Hispanics (AAPC = -0.93, 95% CI = -4.03 to 2.28) and non-Hispanic whites (AAPC = -1.67, 95% CI = -2.88 to -0.45); nevertheless, the differences were not statistically significant (Supplemental Table E3 a ). Age-adjusted mortality owing to Alzheimer disease seemed to increase the most for Asian/Pacific Islander (AAPC = 6.06, 95% CI = -5.71 to 19.31) compared with those of Hispanics (AAPC = 2.70, 95% CI = -5.59 to 11.73), non-Hispanic whites (AAPC = 2.14, 95% CI = -2.56 to 7.07) and African Americans (AAPC = -0.62, 95% CI = -13.82 to 14.61), respectively. However, there was no statistically significant difference.
Trends of age-adjusted CVD mortality rates were similar to those of heart disease (Supplemental Table E4 a ).
DISCUSSION
The current study was conducted in a large cohort of Health Plan enrollees over 16 years. Our findings suggest that despite the fact that the age-adjusted mortality rates declined significantly in all 3 populations (KPSC, CA, and the US), the trends of age-adjusted all-cause and cause-specific mortality rates in KPSC were comparable to those of California and the US. Similarly, when the analyses were stratified by sex and race/ethnicity, the trends of age-adjusted mortality rates in KPSC remained comparable to those of California and the US.
The decline in mortality from heart disease may be attributed to changes in risk factors and progress in treatment. The decreasing prevalence of important cardiovascular risk factors, including cigarette smoking, elevated total cholesterol, high systolic blood pressure, and physical inactivity, were reported to account for almost half of the decrease in death caused by coronary artery disease. 29 Improvement in secondary prevention therapies as well as timely revascularization via coronary artery bypass surgery and percutaneous coronary intervention also contributed to the reduction in cardiovascular mortality. 30 Unfortunately, this trend is offset by major increases in the prevalence of obesity and diabetes, causing a deceleration in the rate of decline between 2011 and 2014 for all cardiovascular deaths. 3 The slowing in rate decline is consistent with the data we reported for the entire US population. The trend in decreasing cardiovascular mortality rate also seemed to slow for KPSC enrollees and California residents since 2011.
The decline in cancer mortality could largely be attributed to screening 31, 32 and more advanced treatment. 33 Other factors affecting cancer mortality included smoking, 34 unhealthy diet, 35 and obesity. 36 The decline in cancer mortality in the US was reported to be stable between 2000 and 2014 by Sidney et al. 3 The same pattern was observed for KPSC enrollees and California residents during the same period.
Although studies have shown associations between air pollution and respiratory and allergic conditions 37 and air quality has been poor in California because of traffic and wildfire-related pollution, 38 California residents experienced lower mortality rates because of chronic lower respiratory tract diseases compared with those of the US in recent years (Supplemental Table E2 a ) . Research based on adult Californians who responded to the Behavioral Risk Factor Surveillance System in 2011 reported an increased risk of chronic obstructive pulmonary disease among white and black residents, compared with Hispanic residents. 39 In KPSC, the mortality rates , 2001-2016 of chronic lower respiratory diseases in non-Hispanic whites and African American populations were higher compared with those of Hispanic and Asian/Pacific Islander.
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Alzheimer disease surpassed chronic lower respiratory diseases in 2004 and cerebrovascular disease in 2007, and became the third leading cause of death among KPSC enrollees. The increasing trend of morality rates of Alzheimer disease was significant in California and the US populations, but not in KPSC. The increase of Alzheimer disease death rates could be attributed to older age at the time of deaths. When advanced medicine prolongs lives and reduces mortality caused by cancer and CVD, people are more likely to die of Alzheimer disease or its complications. Our results, based on KPSC enrollees, showed that the mortality rate due to Alzheimer disease was highest in African American enrollees, followed by non-Hispanic whites enrollees. This result is consistent with what was reported by Taylor et al. 40 Patients with Alzheimer disease typically die because of comorbidities (eg, infections), poor functional status, lack of nutrition, delirium, and severe cognitive impairment. [41] [42] [43] [44] Our findings also suggest that in the KPSC population, Hispanic and Asian/ Pacific Islander enrollees had lower ageadjusted mortality rates, compared with those of African Americans and nonHispanic white enrollees. This finding is similar to that of a meta-analysis in which the authors reported that Hispanics had lower overall mortality than did non-Hispanic whites and non-Hispanic blacks, but overall higher risk of mortality than did Asian Americans. 45 The mortality advantage of Hispanics and Asian/Pacific Islanders may be partially attributable to the healthy immigrant effect, [20] [21] [22] in which those who choose to migrate to another country are in general healthier than those who decide to stay. However, other studies found only weak evidence to support such a hypothesis. 21, 23 Another potential explanation could be the "salmon bias" effect, or reverse immigration hypothesis, in which selective immigrants, especially the less healthy ones, returned to their countries of origin. 24 However, authors of other studies believed that the evidence was not enough 46 or could explain only part of the advantages. 47 The observed lower all-cause and race/ ethnicity-specific mortality rates at KPSC compared with those of California and the US should be interpreted with caution. It is very likely that the advantage in mortality rates is attributable to the better coordination and delivery of care within the integrated health care system. However, it may also be possible that people who joined KPSC were healthier than other local residents because of more stable insurance coverage or healthier lifestyles.
Similar to age-adjusted all-cause mortality, the age-adjusted mortality rates caused by cancer and heart disease also varied significantly among racial/ethnic groups in the KPSC population. Our results are consistent with the US national data between 2010 and 2014 showing that African Americans and non-Hispanic whites had the higher CVD mortality rates (African Americans being the highest and non-Hispanic whites the second highest) compared with those of Hispanic and Asian/Pacific Islander. 3 A study that evaluated the racial/ethnic differences in the risk of coronary heart disease in a cohort of 1.3 million KPNC enrollees showed that compared with whites, blacks, Latinos, and Asians all had a lower risk of coronary heart disease across all clinical risk categories, with the exception of blacks with prior coronary heart disease and no diabetes having higher risk than whites. 48 It is unclear whether or not the lower risk of coronary heart disease may lead to a lower rate of CVD mortality rates in this population.
Some limitations of the present study should be acknowledged. First, one of the factors determining the quality of linkage is the uniqueness of identification of individuals being linked. A higher level of uniqueness is associated with more accurate linkage. The use of common Latino names (surnames and first names) and Asian/Pacific Islander surnames could lead to more false-positive matches and thus affect our ability to identify deaths of Hispanic and Asian/Pacific Islander enrollees. However, when we examined the success rates among 266,398 deaths documented within the KPSC system between 1988 and 2016 for each racial/ ethnic subpopulation, the percentage of deaths not found by the linkage process did not differ much. Specifically, the rates were 2.5% for Hispanic, 1.4% for Asian/ Pacific Islander, 1.3% for African Americans, and 0.8% for non-Hispanic whites. This is at least partially owing to a feature provided by the linkage software that takes care of the level of uniqueness of matching variables.
Second, deaths occurring outside California may not be completely captured, particularly after 2011, when a law was established that prohibited the SSA from disclosing state death records that the SSA receives through its contracts with the states. Given the size of the KPSC population and the lengthy study period, it was not feasible to identify deaths through the National Death Index. However, it is expected that most of the deaths outside California were reported to KPSC for active enrollees by family members, caregivers, doctors from medical facilities outside California, or law enforcement officers.
Third, the cause of death was missing for 27,187 (6.4%) of all deaths. These included deaths that were reported to KPSC or those that were derived through the linkage with SSA records but were not identified through the linkage process with the death records from the State of California. Therefore, the cause-specific death rates could be slightly underestimated.
Fourth, underlying causes of death may be underestimated for certain causes. For example, James et al 49 found evidence that supported a larger number of deaths attributable to Alzheimer disease than what was actually reported.
Fifth, the change of underlying cause of death code from ICD-9 to ICD-10 in 1999 may affect the analyses related to cause of death. Anderson et al 50 studied the influence of migration from ICD-9 to ICD-10 and concluded that the ranking of leading causes of death was substantially affected for some causes of death.
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